Affiliation: Rush University Medical Center
- Patients with positive axillary lymph nodes: how to use genomic assaysRuta Rao
Rush University Medical Center, 1725 W Harrison Street, Chicago, IL 60612, USA
Curr Treat Options Oncol 13:240-8. 2012..Currently, the genomic assays are limited to use in tumors that are estrogen receptor positive. It is still clearly the standard of care to administer chemotherapy to estrogen receptor negative, lymph node positive tumors...
- The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphomaRuta Rao
Section of Hematology, Rush University Medical Center, Chicago, IL 60612, USA
Clin Lymphoma 6:26-30. 2005....
- Lymphomatoid granulomatosis treated with rituximab and chemotherapyRuta Rao
Department of Hematology/Oncology, Rush University Medical Center, Chicago, IL 60612, USA
Clin Adv Hematol Oncol 1:658-60; discussion 660. 2003
- Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology GroupRuta D Rao
Rush University Medical Center, 1725 W Harrison St, Suite 809, Chicago, IL 60612, USA
Med Oncol 28:S39-47. 2011..This trial provides important toxicity information about fenretinide, a retinoid that has been used in the prevention setting, because it is the only placebo-controlled, double-blind randomized study ever performed...
- A community effort to reduce the black/white breast cancer mortality disparity in ChicagoDavid Ansell
544 Academic Facility, Rush University Medical Center, 600 South Paulina Avenue, Chicago, IL 60612, USA
Cancer Causes Control 20:1681-8. 2009..The Taskforce explored three hypotheses: black women in Chicago receive fewer mammograms, black women receive mammograms of inferior quality, and black women have inadequate access to quality of treatment for breast cancer...